Investigation of a link between raised levels of pepsinogen in blood as a mediator of in-vitro clot lysis in acid and a cause of abnormal factor XIII screening tests

Simple item page
dc.contributor.authorDuncan, E.
dc.contributor.authorDale, B.
dc.contributor.authorLloyd, J.
dc.date.issued2014
dc.description.abstractAbstract not available
dc.description.statementofresponsibilityElizabeth M. Duncan, Brian J. Dale and John V. Lloyd
dc.identifier.citationBlood Coagulation and Fibrinolysis, 2014; 25(4):340-348
dc.identifier.doi10.1097/MBC.0000000000000037
dc.identifier.issn0957-5235
dc.identifier.issn1473-5733
dc.identifier.urihttp://hdl.handle.net/2440/92705
dc.language.isoen
dc.publisherLippincott, Williams & Wilkins
dc.rights© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
dc.source.urihttps://doi.org/10.1097/mbc.0000000000000037
dc.subjectaspartic proteases; clot lysis; coagulation inhibitor; factor XIII; gastricin; pepsin; pepsinogen
dc.titleInvestigation of a link between raised levels of pepsinogen in blood as a mediator of in-vitro clot lysis in acid and a cause of abnormal factor XIII screening tests
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Medicine publications